Posted by AGORACOM-JC
at 4:42 PM on Tuesday, December 22nd, 2020
The dawn of the psychedelics industry could not have come at a more needed time for humanity, as global events have served to exacerbate mental health issues related to anxiety and depression. Investors will need help identifying best of breed psychedelics companies and a review of the Red Light Holland story is all you need to know about where the Company is going.
Red Light Holland (TRIP:CSE) is a psychedelics company focused on the development of premium “magic” truffles in the Netherlands. More than just lip service the Company already has these two very strong pillars in place:
COMMERCIALIZATION – The Company’s recreational brand of magic truffles are already being sold in the Netherlands through existing Smart Shops, as well as, its e-commerce platform through microdose packs. To this end, TRIP has already sold its first 100,000 grams of magic truffles months ahead of schedule, and has now increased production by 10X to 1,000,000 grams (not a typo).
TEAM – In order to help guide the company’s development and operations in the psychedelics space, TRIP has signed former Canopy Growth CEO Bruce Linton as chair of its advisory board and Former Canadian Health Minister, Tony Clement, as Senior Advisor. Company President Hans Derix is a native of the Netherlands and an expert in the space with over a decade of accomplished experience.
As if that wasn’t enough, TRIP has also produced a virtual reality experience for prospective customers who want to experience the effects of their products before actually trying it. The AGORACOM thesis of small cap wealth creation this decade is the convergence of emerging technologies – but even we didn’t foresee the explosive intersection of virtual reality and psychedelics!
If you believe in the future of Psychedelics and Psilocybin in particular, then this interview with Todd Shapiro, CEO of Red Light Holland will be a TRIP.
Posted by AGORACOM-JC
at 10:23 AM on Tuesday, December 22nd, 2020
Announced the appointment of Dr. Michael Gallaway to the Binovi Scientific Advisory Board. Dr. Galloway joins the other members of the board in directing the company’s advancements.
“We are very pleased to welcome Dr. Gallaway to the Scientific Advisory Board. His extensive experience working with children will help tremendously as we push Binovi into the education sector, with our focus on K-12 -and particularly K-3-students,” said Adam Cegielski, Binovi CEO.
TORONTO, ON and NEW YORK, NY / December 22, 2020 / Binovi Technologies Corp., (Binovi) (OTCQB:BNVIF) (TSX-V:VISN) (GR:2EYA) is proud to announce the appointment of Dr. Michael Gallaway to the Binovi Scientific Advisory Board. Dr. Galloway joins the other members of the board in directing the company’s advancements.
“We are very pleased to welcome Dr. Gallaway to the Scientific Advisory Board. His extensive experience working with children will help tremendously as we push Binovi into the education sector, with our focus on K-12 -and particularly K-3-students,” said Adam Cegielski, Binovi CEO.
“I am delighted that Dr. Gallaway has joined our Scientific Advisory Board”, commented Dr. Leonard Press, Binovi Chief Scientific Officer. “His background in scientific research, vision-based learning problems, vision screening, and concussion management, will help take Binovi to another level.”
“I look forward to joining Binovi’s Scientific Advisory Board especially as the company is targeting more advanced school screening protocols and interventions for children,” said Dr. Gallaway, Binovi Scientific Advisory Board Member.
About Dr. Michael Gallaway
Dr. Gallaway is board certified in vision therapy as a Fellow in the College of Optometrists in Vision Development (COVD), and is a Fellow in the American Academy of Optometry (AAO). He has been in private practice in the South Jersey area since 1989, specializing in vision therapy and children’s vision disorders. He is also an Associate Professor at the Pennsylvania College of Optometry at Salus University in Philadelphia. In addition to his teaching, he is involved in research in learning related vision problems, amblyopia, vision therapy for convergence insufficiency, and concussion-related vision problems. He has published many articles in optometric journals and has lectured extensively in the US and internationally on children’s vision and vision therapy.
Dr. Gallaway was the Principal Investigator at Salus/PCO for CITT-ART, a National Eye Institute funded nationwide study assessing the impact of vision therapy for convergence insufficiency on reading and attention. In 2015, Dr. Gallaway received the Skeffington Award for Excellence in Optometric Writing from the College of Optometrists in Vision Development in recognition of his scholarly writing and research over his career. Dr. Gallaway was also the Principal Investigator at Salus University for the Convergence Insufficiency Treatment Trial (CITT), an NIH funded randomized multicenter clinical trial that was published in 2008.
Dr. Gallaway was also an Investigator both in his office and at Salus University for the Pediatric Eye Disease Investigator Group (PEDIG) studying the Amblyopia Treatment Studies, which Dr. Gallaway has participated in from 2001 to 2019.
Binovi is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. As a SAAS based solution, the Binovi Connect App is supported by specialized expert knowledge, unique data insights and supporting hardware to deliver customized, one-on-one cognitive training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Binovi is currently used in over 20 countries.
Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 9:09 AM on Tuesday, December 22nd, 2020
Announced that its common shares will commence trading on the OTCQB ® Venture Market in the United States under the symbol “PLTXF” effective December 22, 2020 .
The OTCQB Venture Market is for early-stage and developing companies. In order to be eligible, companies must be current in their financial reporting, pass a minimum bid price test and undergo an annual company verification and management certification process.
The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.
VANCOUVER, BC , Dec. 22, 2020 – PlantX Life Inc. (the ” Company ” or ” PlantX “) (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF) is pleased to announce that its common shares will commence trading on the OTCQB ® Venture Market in the United States under the symbol “PLTXF” effective December 22, 2020 .
The OTCQB Venture Market is for early-stage and developing companies. In order to be eligible, companies must be current in their financial reporting, pass a minimum bid price test and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.
PlantX continues to advance its plans to open its first brick and mortar locations in San Diego, California and Squamish, British Columbia , with plans of future franchising across North America . PlantX will also continue to expand its e-commerce capabilities around the world with new and exciting partnerships, acquisitions and verticals in the plant-based industry.
The Company’s digital platforms PlantX.com and PlantX.ca currently make available thousands of plant-based products from top brands in the industry, offer indoor plant delivery, a restaurant locator, weekly-curated plant-based recipes, news articles and blogs. PlantX also recently announced its newly-formed Medical Advisory Board comprised of medical professionals from around the world to guide and support the Company’s products, recipes and educational offerings with medical and scientific expertise.
“The addition of another trading platform will continue to increase PlantX’s visibility with investors,” said Sean Dollinger , PlantX founder. “We as a company know plant-based living is the future, and it’s great that our investors and shareholders will be able to share in that excitement.”
PlantX’s shares will continue to trade on the Canadian Securities Exchange (CSE) under its existing symbol “VEGA” and the Frankfurt Exchange under the symbol “WNT1”.
As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.
Forward-Looking Information
This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation, statements regarding the commencement of the trading of the Company’s common shares on the OTCQB Venture Market, the expansion of the Company’s e-commerce capabilities, the opening of the Company’s new brick and mortar locations in San Diego, CA and Squamish, B.C and the business and strategic plans of the Company.
By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.
Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 8:59 AM on Tuesday, December 22nd, 2020
In 2020 the Company’s primary objective was to follow up on recommendations made in the 2019 River Valley Palladium Project Preliminary Economic Assessment (PEA).
The River Valley Palladium Project is one of North America’s largest undeveloped primary Platinum Group Metal (PGM) projects. The Project has excellent infrastructure and is within 100 kilometres of the Sudbury Metallurgical Complex. The Project is 100% owned by New Age Metals.
The Company completed a three-phase exploration and development plan at River Valley which included drilling, environmental, and archaeological studies.
The Company also completed follow-up mapping and sampling programs on its Lithium One Project in Southeast Manitoba. The program was co-funded by the Manitoba Chamber of Commerce’s, Manitoba Mineral Development Fund (MMDF). In December the Company received a drill permit for its Lithium Two Project and a permit is pending for Lithium One. Further drill target definition surveys are being contemplated for 2021.
The Company is expecting results and corresponding press releases from both its rhodium evaluation program at River Valley and the surface sampling program from its Lithium One Project in Manitoba before the end of January 2021.
The spot price of an ounce of Palladium increased by over 18% in the last year, to $US2,220/oz as at December 21, 2020. Rhodium, which is also present at River Valley, has seen a price increase of over 160% year-to-date to $US16,000/ oz.
The Company is actively seeking an option/joint venture partner for our Genesis PGM-Cu-Ni Project in Alaska and for our Lithium division in Manitoba.
December 22, 2020 – Rockport, Canada – New Age Metals Inc. (TSXV:NAM ) | ( OTC:NMTLF ) | ( FSE:P7J) Harry Barr, Chairman & CEO, stated ; “We are pleased to provide shareholders with a year end review of our activities in 2020 and a view of our exploration and development plans for our portfolio of green metal projects in 2021.”
The Company’s primary objective this year was to follow-up on recommendations made in the 2019 River Valley Project PEA. To that end we have completed a three-phase exploration and development plan which included two rounds of drilling, initiated environmental baseline and archaeological studies, and have commenced a phase one rhodium evaluation program with the objective of including rhodium as a payable metal.
As we progress into 2021, we are focused on advancing River Valley to a Prefeasibility study. This would include recommendations to complete metallurgy, hydrogeology, geotechnical surveys, an updated mineral resource estimate, environmental baseline, infill and exploration drilling. Management is currently soliciting quotes from third party engineering firms with the objective of completing a final Prefeasibility budget by the end of February 2021. Subject to the completion of additional funding we plan to initiate this study by the third quarter of 2021 and our objective is to complete the Prefeasibility study by the end of the first quarter of 2022.
Genesis PGM-Cu-Ni Project
The Genesis PGM-Cu-Ni Project is an under explored, highly prospective drill ready property. In 2020 NAM’s management continued to seek an option/joint-venture partner for this road accessible PGM-Cu-Ni Project using the Prospector Generator business model. COVID-19 disrupted property visits which in turn hindered any finalization of a potential option / joint venture deal. The Company paid for all holding costs in 2020 and the project remains in good standing. The stable land status, ease of access and superb infrastructure make this project prospective for year-around exploration, and development.
2020 Exploration and 2021 Plans for Lithium Division
The Company has several Lithium and Rare Element Projects in the Winnipeg River Pegmatite Field, located in South East Manitoba and situated around the Tanco Mine. The world-class Tanco Pegmatite is a highly fractionated lithium-cesium-tantalum (LCT)–type pegmatite that has historically been mined (Tanco Mine) since 1969 for Li, Ta, Cs, Rb and Be ores. The Tanco Pegmatite is a very rich tantalum and cesium deposit with it being the world’s most significant and richest known source of cesium representing more than two-thirds of the world’s reserve.
In 2020, the company conducted a follow-up round of surface exploration work on its Lithium One Project to generate future drill targets. This program was co-funded by a grant from Manitoba Chamber of Commerce’s, Manitoba Mineral Development Fund (MMDF). Over 80 samples have been sent to a laboratory in Saskatchewan and results are expected in January. Samples from a previous work program on the project were taken from the Silverleaf and Annie pegmatites and not only returned significant Li20 assays of up to 4.1% but heightened levels of Rubidium Oxide (Rb2O).
Management plans to make a second application for a grant from the MMDF in 2021. In December 2020 the Company received a drill permit for its Lithium Two Project and the application for a permit on Lithium One was submitted to the Manitoba government. The Company continues to solicit potential option/joint venture partner(s) to continue the development of its Lithium division.
Shares for Services
The Company has issued 135,600 common shares at a deemed value of $0.10 per share to Agora Internet Relations Corp. (“AGORACOM”) pursuant to the terms of the March 2020 agreement. The securities issued represent the fourth payment for services under the terms of the agreement and are subject to a four month plus one day hold period expiring April 22, 2021.
Opt-in List
If you have not done so already, we encourage you to sign up on our website ( www.newagemetals.com ) to receive our updated news.
About NAM
New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America. The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned, multi-million-ounce, district scale River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 km from Sudbury, Ontario. The Company has recently completed a Preliminary Economic Assessment on the project and is working towards Prefeasibility. In Alaska the Company owns 100% of the Genesis PGM-Cu-Ni Project.
The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field, where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. The Company is actively seeking an option/ joint venture partner for its road-accessible Genesis PGM-Cu-Ni project in Alaska and for our Lithium division in Manitoba.
Investors are invited to visit the New Age Metals website at www.newagemetals.com where they can review the company and its corporate activities. Any questions or comments can be directed to [email protected] or Harry Barr at[email protected]or Cody Hunt at[email protected]or call 613 659 2773.
On behalf of the Board of Directors
“Harry Barr”
Harry G. Barr
Chairman and CEO
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.
Posted by AGORACOM-JC
at 8:54 AM on Tuesday, December 22nd, 2020
Announced agreements to install Delta-X Trust units in a Vaughan retirement home, and a sports and school complex.
As previously announced in a November 23, 2020 press release, UPI entered into an agreement with the Delta-X Group to test the Delta-X Trust proprietary face and temperature recognition software technology, with clients across Canada.
COVID-19 has infected more than 485,000 people in Canada with over 13,800 deaths. While the Canadian Government expects to vaccinate the majority of Canadians by the end of 2021, it is still unclear as to the length of time that vaccines will protect Canadians.
Technology such as Delta-X Trust can be a key tool to manage the flow of people in and out of high traffic public and private facilities, providing property managers with the protocols to improve the safety of the tenants and visitors to a site.
Toronto, Ontario–(December 22, 2020) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or “the Company”) is pleased to announce agreements to install Delta-X Trust units in a Vaughan retirement home, and a sports and school complex.
As previously announced in a November 23, 2020 press release, UPI entered into an agreement with the Delta-X Group to test the Delta-X Trust proprietary face and temperature recognition software technology, with clients across Canada. To this end, UPI has entered into agreements with UniversalCare Canada Inc. to install Delta-X unit within its Richview Retirement Residence facility, and with Mentana Group Inc. to install unit within their Vaughan Sports Village facility.
“The Company is pleased to be able to deploy the Delta-X Trust units at the Richview Retirement Residence, a premier Independent and Assisted Living home, and Sports Village, a multi-rink and school complex,” stated UPI CEO Chris Hazelton. “The Company and each of these facilities will scope out the unit protocols over the coming weeks to ensure the units provide additional security and protection for users of the facilities, and the Company expects installation to be completed in coming weeks. Seniors homes, schools and other institutional facilities are among the highest risk facilities to prevent the spread of COVID-19, and we are pleased that we can be part of the solution.”
COVID-19 has infected more than 485,000 people in Canada with over 13,800 deaths. While the Canadian Government expects to vaccinate the majority of Canadians by the end of 2021, it is still unclear as to the length of time that vaccines will protect Canadians. Technology such as Delta-X Trust can be a key tool to manage the flow of people in and out of high traffic public and private facilities, providing property managers with the protocols to improve the safety of the tenants and visitors to a site. These pilots are expected to provide the Company with better visibility regarding the interaction between key stakeholders, integration within building systems, and will inform wider go-to-market strategies. Other clients of the Company have expressed an interest to have Delta-X Trust units installed, and the Company will continue to refine the strategy to scale the opportunities.
New Technology – DELTA-X Trust
Delta-X™ Trust is a technology package that offers building administrators touchless facial recognition, temperature detection and multi-factor authentication (MFA) technology to improve hygiene and security standards in any public, high-risk or restricted-access environment. Delta-X™ Trust solutions can be applied to communities, office buildings, bus stations, airports, hotels, schools, hospitals, sports facilities and other public places with heavy traffic, helping to achieve intelligent security management and disease prevention.
About Universal PropTech Inc.
Universal PropTech Inc. (TSXV: UPI) is a leading building innovation company, selecting, integrating, deploying and maintaining PropTech in healthy buildings. As trusted advisors, we provide holistic evidence-driven solutions and services for building developers, owners and operators in Canada.
UPI operates through its wholly-owned subsidiary, VCI Controls Inc. (“VCI”), a leading supplier and integrator of PropTech healthy building solutions and services. VCI is an industry leader in the acquisition and deployment of intelligent building technology, including the integration of all building systems utilizing the latest in communications technologies and standards. VCI’s business focuses on digital controls and mechanical services, performance monitoring, and energy efficiency solutions.
With headquarters in Toronto, Universal PropTech has offices across Canada including, Halifax, Montreal, and Ottawa. For more information, visit www.universalproptech.com
Certain statements in this press release are forward-looking statements. The reader is cautioned that assumptions used in the preparation of such information, although considered reasonable by the Company at the time of preparation, may prove to be incorrect. Forward-looking statements, specifically those concerning future performance and other statements that are not historical fact, are subject to certain risks and uncertainties, and actual results may differ materially from the Company’s plans and expectations. These plans, expectations, risks and uncertainties are detailed herein and from time to time in the filings made by the Company with the TSX Venture Exchange (the “Exchange”) and securities regulators. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Trading in the securities of the Company should be considered highly speculative. All forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement.
Neither the Exchange, nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
Posted by AGORACOM-JC
at 8:47 AM on Tuesday, December 22nd, 2020
Company has submitted a formal application to list its common shares on the NASDAQ Stock Exchange .
NASDAQ is the second largest exchange by market capitalization worldwide and is home to many of the world’s best technology companies.
In connection with its application to list on NASDAQ, PyroGenesis will, in due course, file a Form 40-F Registration Statement with the United States Securities and Exchange Commission (SEC)
MONTREAL, Dec. 22, 2020 — PyroGenesis Canada Inc. ( http://pyrogenesis.com ) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that, further to its Press Release dated December 8 th , 2020, the Company has submitted a formal application to list its common shares (“Shares”) on the NASDAQ Stock Exchange (“NASDAQ”). NASDAQ is the second largest exchange by market capitalization worldwide and is home to many of the world’s best technology companies.
In connection with its application to list on NASDAQ, PyroGenesis will, in due course, file a Form 40-F Registration Statement with the United States Securities and Exchange Commission (SEC). The listing of the Company’s Shares on NASDAQ remains subject to the approval of NASDAQ and the satisfaction of all applicable listing and regulatory requirements. Based on its typical review process, and according to NASDAQ’s website, the process usually takes 6 to 8 weeks. Therefore, it is expected that the Company’s Shares will be listed before the end of Q1 2021.
“We believe the Company is entering a heightened growth phase and the timing could not be better for uplisting our Shares to NASDAQ,” said Mr. P. Peter Pascali, CEO & Chair of PyroGenesis. “We expect that the move to NASDAQ will increase awareness of PyroGenesis, and its offerings, both within the financial community and amongst potential clients. We believe this listing will also enhance trading liquidity by broadening our appeal to a larger shareholder base, in the US and internationally, as we execute our business plan and drive long-term shareholder value. We are very much looking forward to elevating the Company’s profile with this listing.”
As previously disclosed, there will not be a concurrent financing associated with this listing nor will there be a reverse stock split.
The Company will continue to maintain the listing of its Shares on the Toronto Stock Exchange (“TSX”), and would trade on both exchanges under the ticker symbol “PYR.”
The Company has engaged Nelson Mullins Riley & Scarborough LLP as its US legal counsel to process the NASDAQ listing.
About PyroGenesis Canada Inc. PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m 2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found atwww.sedar.com ,or atwww.otcmarkets.com .Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release. SOURCE PyroGenesis Canada Inc.
For further information please contact: Rodayna Kafal, Vice President, IR/Comms. and Strategic BD Phone: (514) 937-0002, E-mail: [email protected] RELATED LINK: http://www.pyrogenesis.com/
Posted by AGORACOM-JC
at 8:11 AM on Tuesday, December 22nd, 2020
Announced that it has closed its Non-Brokered Private Placement of units for gross proceeds of approximately $3 Million previously announced on December 10, 2020.
A total of 19,999,997 Units were issued at a purchase price of $0.15 per Unit, with each Unit comprised of one common share of the Company and one Common Share purchase warrant
Each Warrant is exercisable to acquire one Common Share at an exercise price of $0.20 per Warrant Share for a period of 24 months from the closing.
TORONTO, ON / December 22, 2020 /KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America” or “KABN NA“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has closed its Non-Brokered Private Placement of units (“Units“) for gross proceeds of approximately $3 Million (the “Non-Brokered Offering“) previously announced on December 10, 2020. A total of 19,999,997 Units were issued at a purchase price of $0.15 per Unit, with each Unit comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant is exercisable to acquire one Common Share (a “Warrant Share“) at an exercise price of $0.20 per Warrant Share for a period of 24 months from the closing. The Units will have a hold period of four months and one day from the applicable closing.
“We are pleased to welcome a number of new investors and financial services firms as Company shareholders. The interest in the offering was in excess of the available units, even after the increase in the offering from $2 Million to $3 Million,” said David Lucatch, CEO. “We would also like to welcome Mr. Rob Anson, CEO of Loop Insights Inc., and Mr. Sheldon Inwentash, Founder, Chairman and CEO of ThreeD Capital, both as new investors in KABN NA and as members of our Industry Advisory Committee to support the Company with its future growth.”
In connection with the Non-Brokered Offering, the Company paid finder’s fee in the aggregate sum of $130,620 and issued 990,800 compensation options (the “Finders’ Options“) to certain eligible finders. Each Finders’ Option entitles the holder to purchase one Unit at an exercise price equal to C$0.15 per Unit at any time up to 24 months following closing.
The Company’s previously announced brokered private placement of up to $1.15 Million is expected to close on or about December 29, 2020, or on such earlier date as agreed upon between the Company and the agent, and is subject to certain conditions, including receipt of subscription agreements and payment of the subscription amounts by subscribers.
The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.
Update on Family Office Financing With respect to the US-led Family Office financing originally announced on August 18, 2020, with subsequent updates made on September 16, and October 22, 2020, the subscribers have failed to date to fund their commitments. On December 8, 2020, the Company delivered demand letters to the subscribers, demanding that they close by December 11, 2020. Having failed to do so, the Company views these agreements as being at an end, and has demanded that the subscribers reimburse the Company for the costs it has incurred in respect of these subscriptions. The Company is reserving its rights to take further action in the future.
About KABN North America – www.kabnnaholdco.com KABN Systems NA Holdings Corp. through its wholly-owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from the use of their online identity. KABN NA’s propriety technology suite includes 4 key products:
Liquid Avatar allows users to create high-quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allow users to manage and control their Self Sovereign Identity and to use Liquid Avatars to share verifiable credentials, including access, identity and designation credentials, and public and permission-based private data when they want and with whom they want. www.liquidavatar.com
KABN ID is an Always On, biometric and blockchain-based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.
KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com
KABN KASH is a cashback, loyalty and engagement program that powers the KABN NA’s revenue ecosystem. KABN NA provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com
Posted by AGORACOM-JC
at 7:41 AM on Tuesday, December 22nd, 2020
Announced the launch of its 2nd fulfillment depot for its direct-to-consumer cannabis delivery platform, Dreamy Delivery
Company soft launched Dreamy Delivery to friends and family in the San Francisco Bay Area of Northern California , to ensure a seamless customer experience in early Q4 of 2020.
The Company has expanded the Platform, with Dreamy now successfully delivering to legal cannabis consumers in the San Francisco Bay Area of Northern California and now Sacramento , California.
VANCOUVER, BC , Dec. 22, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the ” Company “, ” Hollister Cannabis Co. ” or ” Hollister “) a diversified cannabis branding company with products in over 280 dispensaries throughout California , and over 80 dispensaries throughout Arizona , is pleased to announce the launch of its 2nd fulfillment depot for its direct-to-consumer cannabis delivery platform, Dreamy Delivery (” Dreamy ” or the ” Platform “).
The Company soft launched Dreamy Delivery to friends and family in the San Francisco Bay Area of Northern California , to ensure a seamless customer experience in early Q4 of 2020. The Company has expanded the Platform, with Dreamy now successfully delivering to legal cannabis consumers in the San Francisco Bay Area of Northern California and now Sacramento , California. The Company hopes to launch Dreamy in the Central Coast of California by early Q1 of 2021 with the ultimate goal of delivering Cannabis statewide.
Carl Saling , CEO of Hollister , shared, “Very excited to have opened our 2nd direct to consumer delivery depot in record time, allowing us to serve legal adults in the Sacramento Area . This furthers our quest to be a dominate direct to consumer delivery platform in California .”
Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.
The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com .
Posted by AGORACOM-JC
at 7:32 AM on Tuesday, December 22nd, 2020
Understanding the world of Photonics isn’t the easiest thing small cap investors have had to understand. In fact, it may be the very hardest thing they’ve ever had to understand. However, given the fact we are the very reason current photonics devices aren’t living up to snuff trying to keep up with our surfing, streaming, binging and zooming – you start to see why understanding photonics and POET Technologies could open up investors to a whole new world.
We went beyond the press release with POET management to discuss the “Industry’s First Flip-Chip DML Lasers” No, we didn’t understand the title at first either ….. but the management trio on the Zoom did a great job explaining it in terms that are both compelling yet understandable.
Before watching this video, here is some important background information.
Photonics are critical to the next phase of semiconductor development. Semiconductors are an essential component of every electronic device on the planet.
Photonic devices create, detect and manipulate light. Laser generated light is fundamental to sensing, computing, data and telecommunications, which require the fastest transfer of data possible.
In short, all the surfing, streaming, binging and zooming we do requires 2 things to happen:
1. Massive data centres filled with tens of thousands of servers.
2. Speed … and we mean lighting speed that requires lasers to transfer all that data fast enough for you not to complain about 2 second latency when searching for last minute Christmas gift ideas (We see you)
Examples of the the biggest trends sucking up all that power and speed in computing today:
Cloud Computing
Artificial Intelligence
5G and Edge
HERE IS THE PROBLEM
Making photonics devices that are reliable is expensive in terms of both capital and labour.
Cost declines have not kept up with Moore’s Law, with most photonics devices built one at a time – and multiple different components must be able to interconnect seamlessly without constant testing.
The Result? Integration of components at wafer-scale has not been fully implemented even by the largest companies working for the past 20 years ….. UNTIL NOW
POET has developed a unique, disruptive and differentiating new entry into photonics markets.
The POET Optical Interposer™ Platform – patented photonics integration platform that enables lower cost and higher performance across a wide range of applications.
The press release announcing the industry’s first flip-chip DML lasers might very well take POET to a whole new level.
Watch this great first interview of many with:
Suresh Venkatesan, Chairman and CEO
Vivek Rajgarhia, President & General Manager
Thomas Mika, Executive Vice President and Chief Financial Officer
Posted by AGORACOM-JC
at 10:26 PM on Monday, December 21st, 2020
Sometimes, you just have to let the numbers speak for themselves. With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that any small cap Health & Wellness company would kill for … but then you add in that CBDT has now delivered growth in 5 (FIVE) successive financial reports (Q4, FY 2019, Q1, Q2 and Q3), so it is safe to say that superstar CEO Steve McAuley can officially claim victory on the turnaround he inherited in 2019.
Since that day Empower has made several announcements that grew the Company by several magnitudes again. From record testing contracts to new products, partnerships (We see you Loop Insights $MTRX + SimpliFlying) and a $5.5 MILLION injection from warrant proceeds (that is now closer to $6.8M), McAuley was building the foundations of a health & wellness powerhouse.
Finally, for all the new investors that have joined Empower in the last several weeks, McAuley is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which explains how McAuley has been able to guide Empower Clinics through the most disruptive environment in recent history and turn it into significant growth through Q4 2020 and the foundations to turn it into a powerhouse over the next 3 years.
If you MISSED Well Health and CloudMD, you really need to take a close look at Empower as the next great potential small cap health & wellness company.
